White blood cell count profiles in multiple sclerosis during attacks before the initiation of acute and chronic treatments
Tetsuya Akaishi(Tohoku University Hospital), Atsushi Hozawa(Tohoku University), Rieko Hatanaka(Tohoku University), Shuhei Nishiyama(Fukushima Medical University), Toshiyuki Takahashi(Fukushima Medical University), Mana Kogure(Tohoku University), Fumi Itabashi(Tohoku University), Ichiro Nakashima(Tohoku Medical and Pharmaceutical University), Ikumi Kanno(Tohoku University), Kimihiko Kaneko(Tohoku University), Kazuo Fujihara(Tohoku University), Hiroshi Kuroda(Fukushima Medical University), Masashi Aoki(Tohoku University), Juichi Fujimori(Fukushima Medical University), Naoki Nakaya(Tohoku University), Tomohiro Nakamura(Tohoku University), Tadashi Ishii(Tohoku University Hospital), Yoshiki Takai(Fukushima Medical University), Tatsuro Misu(Tohoku University)
Cited by 33
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
|Neurology|2015|4.6k
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
|The Lancet|2004|3.2k
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740